Literature DB >> 10762600

Tumor suppressor p53: regulation and function.

K Somasundaram1.   

Abstract

The p53 protein is a transcription factor involved in maintaining genomic integrity by controlling cell cycle progression and cell survival. Mutations in p53 are the most frequently seen genetic alterations in human cancer. The function of p53 is critical to the way many cancer treatments kill cells because radiotherapy and chemotherapy act in part by triggering programmed cell death in response to DNA damage. Consequently, tumors which bear p53 mutations, are often difficult to treat and their prognosis is poor. Since the underlying feature of tumors with p53 mutations is the absence of functional p53, gene replacement therapy with wild-type p53 gene is being considered as an approach for treating a variety of cancers. In recent years, more information has been obtained regarding various pathways leading to the activation of p53, particularly those involving post-translational modifications of p53. Several new target genes of p53 have been identified. This review will summarize current knowledge on the structure, mechanism of activation and effectors of p53 function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762600     DOI: 10.2741/somasund

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  24 in total

1.  Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition.

Authors:  D G Pestov; Z Strezoska; L F Lau
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

2.  Two internal ribosome entry sites mediate the translation of p53 isoforms.

Authors:  Partho Sarothi Ray; Richa Grover; Saumitra Das
Journal:  EMBO Rep       Date:  2006-01-20       Impact factor: 8.807

3.  Comparative proteomic analysis of SLC13A5 knockdown reveals elevated ketogenesis and enhanced cellular toxic response to chemotherapeutic agents in HepG2 cells.

Authors:  Tao Hu; Weiliang Huang; Zhihui Li; Maureen A Kane; Lei Zhang; Shiew-Mei Huang; Hongbing Wang
Journal:  Toxicol Appl Pharmacol       Date:  2020-07-04       Impact factor: 4.219

4.  Aberrant promoter hypermethylation of p21 (WAF1/CIP1) gene and its impact on expression and role of polymorphism in the risk of breast cancer.

Authors:  Marjan Askari; Ranbir Chander Sobti; Mohsen Nikbakht; Suresh C Sharma
Journal:  Mol Cell Biochem       Date:  2013-09-05       Impact factor: 3.396

5.  Translational control of human p53 expression in yeast mediated by 5'-UTR-ORF structural interaction.

Authors:  R Mokdad-Gargouri; K Belhadj; A Gargouri
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

Review 6.  Novel HIV-1 therapeutics through targeting altered host cell pathways.

Authors:  William Coley; Kylene Kehn-Hall; Rachel Van Duyne; Fatah Kashanchi
Journal:  Expert Opin Biol Ther       Date:  2009-11       Impact factor: 4.388

7.  Alterations in tumour suppressor gene p53 in human gliomas from Indian patients.

Authors:  Poornima Phatak; S Kalai Selvi; T Divya; A S Hegde; Sridevi Hegde; Kumaravel Somasundaram
Journal:  J Biosci       Date:  2002-12       Impact factor: 1.826

8.  Significance of p53 and CD31 in astrogliomas.

Authors:  Abdul-Zaher M Khattab; Magdy I Ahmed; Mohamed A Fouad; Waleed A Essa
Journal:  Med Oncol       Date:  2008-09-20       Impact factor: 3.064

9.  Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway.

Authors:  Pradip Nair; Kumaravel Somasundaram; Sudhir Krishna
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Identification of two novel functional p53 responsive elements in the herpes simplex virus-1 genome.

Authors:  Jui-Cheng Hsieh; Ryan Kuta; Courtney R Armour; Paul E Boehmer
Journal:  Virology       Date:  2014-05-29       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.